Home > Technical section > Biotechnology > Biotech companies > Asuragen


Friday 14 December 2007


Asuragen, Inc. is an oncology molecular diagnostic company and molecular biology service provider.

On April 16th 2007, , Asuragen announced it has granted a non-exclusive license to Agendia, B.V., a gene expression analysis-based diagnostics and clinical testing company. Under the terms of this agreement, Agendia has the right to use RNARetain globally for human diagnostic applications.